BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10421542)

  • 1. Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma. American Joint Committee on Cancer.
    Ozyar E; Yildiz F; Akyol FH; Atahan IL
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1079-87. PubMed ID: 10421542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective comparison of the AJCC 5th edition classification for nasopharyngeal carcinoma with the AJCC 4th edition: an experience in Taiwan.
    Chien CR; Chen SW; Hsieh CY; Liang JA; Yang SN; Huang CY; Lin FJ
    Jpn J Clin Oncol; 2001 Aug; 31(8):363-9. PubMed ID: 11574628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma.
    Chua DT; Sham JS; Wei WI; Ho WK; Au GK
    Cancer; 2001 Dec; 92(11):2845-55. PubMed ID: 11753958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma.
    Pan J; Xu Y; Qiu S; Zong J; Guo Q; Zhang Y; Lin S; Lu JJ
    Am J Clin Oncol; 2015 Apr; 38(2):189-96. PubMed ID: 23608833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of Ho's, International Union Against Cancer, and American Joint Committee stage classifications for nasopharyngeal carcinoma.
    Teo PM; Leung SF; Yu P; Tsao SY; Foo W; Shiu W
    Cancer; 1991 Jan; 67(2):434-9. PubMed ID: 1985736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?
    Ma J; Mai HQ; Hong MH; Cui NJ; Lu TX; Lu LX; Mo HY; Min HQ
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1181-9. PubMed ID: 11483327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
    Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment results of 59 young patients with nasopharyngeal carcinoma.
    Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study.
    Kang M; Long J; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
    Oncotarget; 2016 Mar; 7(12):15252-61. PubMed ID: 26918446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
    Kang M; Zhou P; Liao X; Xu M; Wang R
    Oral Oncol; 2017 Dec; 75():100-105. PubMed ID: 29224805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogram analysis of diffusion kurtosis imaging of nasopharyngeal carcinoma: Correlation between quantitative parameters and clinical stage.
    Xu XQ; Ma G; Wang YJ; Hu H; Su GY; Shi HB; Wu FY
    Oncotarget; 2017 Jul; 8(29):47230-47238. PubMed ID: 28525383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
    Zong J; Lin S; Lin J; Tang L; Chen B; Zhang M; Zhang Y; Xu L; Chen Y; Xiao Y; Fang Y; Pan J
    Oral Oncol; 2015 Mar; 51(3):254-9. PubMed ID: 25467207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and suggestion of eighth T classifications of the UICC/AJCC staging system for nasopharyngeal carcinoma patients: a retrospective analysis.
    Li Y; Ou X; Hu C
    Jpn J Clin Oncol; 2018 Oct; 48(10):927-933. PubMed ID: 30113640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea.
    Kim KH; Yang SS; Yoon YS; Lim SB; Yu CS; Kim JC
    Colorectal Dis; 2011 Aug; 13(8):e220-6. PubMed ID: 21689314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal carcinoma patients with retropharyngeal lymph node metastases: a minimum axial diameter of 6 mm is a more accurate prognostic predictor than 5 mm.
    Li YZ; Xie CM; Wu YP; Cui CY; Huang ZL; Lu CY; Wu PH
    AJR Am J Roentgenol; 2015 Jan; 204(1):20-3. PubMed ID: 25539232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome for nasopharyngeal carcinoma in University Malaya Medical Centre from 2004-2008.
    Chee Ee Phua V; Loo WH; Yusof MM; Wan Ishak WZ; Tho LM; Ung NM
    Asian Pac J Cancer Prev; 2013; 14(8):4567-70. PubMed ID: 24083703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy.
    Liang ZG; Chen XQ; Niu ZJ; Chen KH; Li L; Qu S; Su F; Zhao W; Li Y; Pan XB; Zhu XD
    PLoS One; 2016; 11(12):e0168470. PubMed ID: 27973544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.